Brave New World: State of the Industry 2026

The life science industry is in a new era. The next 5 years will be shaped by healthcare policy, access and economic pressures, mega-blockbusters, and the intersection of AI and consumerism. Major policies like the Inflation Reduction Act, Most Favored Nation, and PBM Reform converge with hypercompetition and rising costs of promotion to shorten the product lifecycle and challenge return on investment. Navigating the future requires understanding where and how fast the market is moving. In this session we will look at the past, present, and future to help you build winning strategies for a Brave New World where everything matters. This is one session you do not want to miss!